| UniProt ID | DCE2_HUMAN | |
|---|---|---|
| UniProt AC | Q05329 | |
| Protein Name | Glutamate decarboxylase 2 | |
| Gene Name | GAD2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 585 | |
| Subcellular Localization |
Cytoplasm, cytosol . Cytoplasmic vesicle . Cell junction, synapse, presynaptic cell membrane Lipid-anchor . Golgi apparatus membrane Peripheral membrane protein Cytoplasmic side . Associated to cytoplasmic vesicles. In neurons, cytosolic leafle |
|
| Protein Description | Catalyzes the production of GABA.. | |
| Protein Sequence | MASPGSGFWSFGSEDGSGDSENPGTARAWCQVAQKFTGGIGNKLCALLYGDAEKPAESGGSQPPRAAARKAACACDQKPCSCSKVDVNYAFLHATDLLPACDGERPTLAFLQDVMNILLQYVVKSFDRSTKVIDFHYPNELLQEYNWELADQPQNLEEILMHCQTTLKYAIKTGHPRYFNQLSTGLDMVGLAADWLTSTANTNMFTYEIAPVFVLLEYVTLKKMREIIGWPGGSGDGIFSPGGAISNMYAMMIARFKMFPEVKEKGMAALPRLIAFTSEHSHFSLKKGAAALGIGTDSVILIKCDERGKMIPSDLERRILEAKQKGFVPFLVSATAGTTVYGAFDPLLAVADICKKYKIWMHVDAAWGGGLLMSRKHKWKLSGVERANSVTWNPHKMMGVPLQCSALLVREEGLMQNCNQMHASYLFQQDKHYDLSYDTGDKALQCGRHVDVFKLWLMWRAKGTTGFEAHVDKCLELAEYLYNIIKNREGYEMVFDGKPQHTNVCFWYIPPSLRTLEDNEERMSRLSKVAPVIKARMMEYGTTMVSYQPLGDKVNFFRMVISNPAATHQDIDFLIEEIERLGQDL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MASPGSGFWS -----CCCCCCCCCC | 28.61 | 8999827 | |
| 6 | Phosphorylation | --MASPGSGFWSFGS --CCCCCCCCCCCCC | 33.91 | 8999827 | |
| 10 | Phosphorylation | SPGSGFWSFGSEDGS CCCCCCCCCCCCCCC | 19.91 | 22817900 | |
| 13 | Phosphorylation | SGFWSFGSEDGSGDS CCCCCCCCCCCCCCC | 30.42 | 22817900 | |
| 30 | S-palmitoylation | PGTARAWCQVAQKFT CHHHHHHHHHHHHHH | 1.97 | 12356867 | |
| 45 | S-palmitoylation | GGIGNKLCALLYGDA CCHHHHHHHHHHCCC | 2.40 | 12356867 | |
| 58 | Phosphorylation | DAEKPAESGGSQPPR CCCCCHHCCCCCCCH | 51.03 | 22210691 | |
| 61 | Phosphorylation | KPAESGGSQPPRAAA CCHHCCCCCCCHHHH | 42.93 | 22210691 | |
| 95 | Phosphorylation | NYAFLHATDLLPACD CCEEEHHHCCCCCCC | 19.21 | - | |
| 121 | Phosphorylation | VMNILLQYVVKSFDR HHHHHHHHHHHHCCC | 13.74 | 26699800 | |
| 125 | Phosphorylation | LLQYVVKSFDRSTKV HHHHHHHHCCCCCCE | 22.29 | 26699800 | |
| 169 | Phosphorylation | HCQTTLKYAIKTGHP HHHHHHHHHHHCCCC | 19.37 | - | |
| 296 | Phosphorylation | AAALGIGTDSVILIK HHHCCCCCCEEEEEE | 24.15 | - | |
| 298 | Phosphorylation | ALGIGTDSVILIKCD HCCCCCCEEEEEEEC | 15.76 | - | |
| 396 | N6-(pyridoxal phosphate)lysine | SVTWNPHKMMGVPLQ CCCCCCCCCCCCCCC | 31.66 | - | |
| 396 | Other | SVTWNPHKMMGVPLQ CCCCCCCCCCCCCCC | 31.66 | - | |
| 515 | Phosphorylation | YIPPSLRTLEDNEER ECCCHHHCCCCHHHH | 39.53 | - | |
| 546 | Phosphorylation | EYGTTMVSYQPLGDK HHCCEEEEEEECCCC | 13.76 | - | |
| 547 | Phosphorylation | YGTTMVSYQPLGDKV HCCEEEEEEECCCCC | 11.62 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DCE2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DCE2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DCE2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DCE1_HUMAN | GAD1 | physical | 7836456 | |
| AR6P1_HUMAN | ARL6IP1 | physical | 25416956 | |
| ATRAP_HUMAN | AGTRAP | physical | 25416956 | |
| TM159_HUMAN | TMEM159 | physical | 25416956 | |
| MAL2_HUMAN | MAL2 | physical | 25416956 | |
| CKLF5_HUMAN | CMTM5 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Palmitoylation | |
| Reference | PubMed |
| "A combination of three distinct trafficking signals mediates axonaltargeting and presynaptic clustering of GAD65."; Kanaani J., El-Din El-Husseini A., Aguilera-Moreno A., Diacovo J.M.,Bredt D.S., Baekkeskov S.; J. Cell Biol. 158:1229-1238(2002). Cited for: SUBCELLULAR LOCATION, AND PALMITOYLATION AT CYS-30 AND CYS-45. | |
| Phosphorylation | |
| Reference | PubMed |
| "Phosphorylation of serine residues 3, 6, 10, and 13 distinguishesmembrane anchored from soluble glutamic acid decarboxylase 65 and isrestricted to glutamic acid decarboxylase 65alpha."; Namchuk M., Lindsay L., Turck C.W., Kanaani J., Baekkeskov S.; J. Biol. Chem. 272:1548-1557(1997). Cited for: PHOSPHORYLATION AT SER-3; SER-6; SER-10 AND SER-13, ANDBIOPHYSICOCHEMICAL PROPERTIES. | |